Lv7
3430 积分 2024-07-11 加入
Extracellular targeted protein degradation: an emerging modality for drug discovery
1小时前
待确认
MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model
1个月前
已完结
Murine T-Cell Transfer Colitis as a Model for Inflammatory Bowel Disease
1个月前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
2个月前
已完结
Myocarditis and autoimmunity
2个月前
已完结
Myocarditis
2个月前
已完结
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA
2个月前
已完结
Treatment of axial spondyloarthritis: an update
2个月前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
2个月前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
4个月前
已完结
皖公网安备34019202002308
